A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders
Top Cited Papers
Open Access
- 10 October 2012
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 49 (10), 660-668
- https://doi.org/10.1136/jmedgenet-2012-101203
Abstract
Background The recurrent ∼600 kb 16p11.2 BP4-BP5 deletion is among the most frequent known genetic aetiologies of autism spectrum disorder (ASD) and related neurodevelopmental disorders. Objective To define the medical, neuropsychological, and behavioural phenotypes in carriers of this deletion. Methods We collected clinical data on 285 deletion carriers and performed detailed evaluations on 72 carriers and 68 intrafamilial non-carrier controls. Results When compared to intrafamilial controls, full scale intelligence quotient (FSIQ) is two standard deviations lower in carriers, and there is no difference between carriers referred for neurodevelopmental disorders and carriers identified through cascade family testing. Verbal IQ (mean 74) is lower than non-verbal IQ (mean 83) and a majority of carriers require speech therapy. Over 80% of individuals exhibit psychiatric disorders including ASD, which is present in 15% of the paediatric carriers. Increase in head circumference (HC) during infancy is similar to the HC and brain growth patterns observed in idiopathic ASD. Obesity, a major comorbidity present in 50% of the carriers by the age of 7 years, does not correlate with FSIQ or any behavioural trait. Seizures are present in 24% of carriers and occur independently of other symptoms. Malformations are infrequently found, confirming only a few of the previously reported associations. Conclusions The 16p11.2 deletion impacts in a quantitative and independent manner FSIQ, behaviour and body mass index, possibly through direct influences on neural circuitry. Although non-specific, these features are clinically significant and reproducible. Lastly, this study demonstrates the necessity of studying large patient cohorts ascertained through multiple methods to characterise the clinical consequences of rare variants involved in common diseases.Keywords
This publication has 45 references indexed in Scilit:
- KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variantNature, 2012
- Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locusNature, 2011
- Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyeliaEuropean Journal of Human Genetics, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- A new highly penetrant form of obesity due to deletions on chromosome 16p11.2Nature, 2010
- Large, rare chromosomal deletions associated with severe early-onset obesityNature, 2010
- Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplicationsJournal of Neurodevelopmental Disorders, 2009
- Microduplications of 16p11.2 are associated with schizophreniaNature Genetics, 2009
- Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a coronin-1A mutation and a chromosome 16p11.2 deletionClinical Immunology, 2009
- Structural Variation of Chromosomes in Autism Spectrum DisorderAmerican Journal of Human Genetics, 2008